Algomedix Competitors and Similar CompaniesClear all
CTI BioPharma's competitors and similar companies include NeurOp and Acticor Biotech.
 CTI BioPharma CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. |  NeurOp NeurOp is a biotechnology company developing medicines for the treatment of central nervous system (CNS) disorders including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression. |  Acticor Biotech Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. | |
Founding Date | Founding Date 1992 | Founding Date 2002 | Founding Date 2013 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Seattle, US HQ Köln, DE | Locations Atlanta, US HQ | Locations Paris, FR HQ Paris, FR |
Employees | Employees 2546% decrease | Employees 6 | Employees 1711% decrease |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 155k (over 12 years ago) | Latest funding round $ 7.8m (over 6 years ago) |
Total funding raised | Total funding raised $ 105m | Total funding raised N/A | Total funding raised $ 33.3m |
For sources of this data, please see the company profile
View Company Profiles
NeurOp
HQ
Atlanta, US
Employees
6
NeurOp is a biotechnology company developing medicines for the treatment of central nervous system (CNS) disorders including stroke, severe pain, subarachnoid hemorrhage (SAH), and treatment-resistant depression.
View companyActicor Biotech
HQ
Paris, FR
Employees
17↓ 11% decrease
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
View company